SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Apr-24 5:27 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 30-Mar-24 | Payment of Exercise | 25,546 | $20.67 | $528,036.00 | (28%) 92.63K to 67.08K | |
02-Apr-24 5:27 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 30-Mar-24 | Option Exercise | 50,404 | -- | -- | 119% 42.22K to 92.63K | |
13-Feb-24 5:39 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Payment of Exercise | 5,083 | $28.80 | $146,390.00 | (11%) 47.3K to 42.22K | |
13-Feb-24 5:39 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Option Exercise | 10,800 | -- | -- | 30% 36.51K to 47.3K | |
30-Jan-24 4:53 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 26-Jan-24 | Option Exercise | 49,325 | $13.06 | $644,047.00 | 135% 36.51K to 85.83K | (3%) |
30-Jan-24 4:53 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 26-Jan-24 | Private Option Sale | 49,325 | $25.66 | $1,265,540.00 | (57%) 85.83K to 36.51K | |
29-Jan-24 5:51 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 25-Jan-24 | Option Exercise | 600 | $13.02 | $7,809.00 | 2% 36.51K to 37.1K | (3%) |
29-Jan-24 5:51 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 25-Jan-24 | Private Option Sale | 600 | $25.00 | $15,000.00 | (2%) 37.1K to 36.51K | |
25-Jan-24 6:26 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 24-Jan-24 | Option Exercise | 11,251 | $13.01 | $146,426.00 | 31% 36.51K to 47.76K | |
25-Jan-24 6:26 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 24-Jan-24 | Option Sale | 11,251 | $25.01 | $281,415.00 | (24%) 47.76K to 36.51K | |
25-Jan-24 6:26 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 23-Jan-24 | Option Exercise | 5,135 | $13.04 | $66,953.60 | 14% 36.51K to 41.64K | (3%) |
25-Jan-24 6:26 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 23-Jan-24 | Private Option Sale | 5,135 | $25.00 | $128,375.00 | (12%) 41.64K to 36.51K | |
10-Jan-24 4:53 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 08-Jan-24 | Option Exercise | 22,913 | $3.26 | $74,696.40 | 63% 36.51K to 59.42K | |
10-Jan-24 4:53 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 08-Jan-24 | Option Sale | 22,913 | $21.13 | $484,124.00 | (39%) 59.42K to 36.51K | |
09-Jan-24 9:28 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 06-Jan-24 | Payment of Exercise | 4,487 | $20.40 | $91,534.80 | (11%) 40.99K to 36.51K | |
09-Jan-24 9:28 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 06-Jan-24 | Option Exercise | 15,285 | -- | -- | 59% 25.71K to 40.99K | |
15-Dec-23 5:14 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 13-Dec-23 | Option Exercise | 1,458 | $10.13 | $14,769.50 | 6% 25.71K to 27.16K | |
15-Dec-23 5:14 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 13-Dec-23 | Option Sale | 1,458 | $20.00 | $29,160.00 | (5%) 27.16K to 25.71K | |
06-Dec-23 5:19 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 04-Dec-23 | Option Exercise | 30,625 | $10.13 | $310,231.00 | 119% 25.71K to 56.33K | |
06-Dec-23 5:19 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 04-Dec-23 | Option Sale | 30,625 | $22.00 | $673,750.00 | (54%) 56.33K to 25.71K | |
13-Feb-23 5:07 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-23 | Payment of Exercise | 3,744 | $4.17 | $15,612.50 | (13%) 29.45K to 25.71K | |
13-Feb-23 5:07 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-23 | Option Exercise | 10,800 | -- | -- | 58% 18.65K to 29.45K | |
02-Mar-22 6:21 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 28-Feb-22 | Payment of Exercise | 1,294 | $9.95 | $12,875.30 | (6%) 19.95K to 18.65K | |
02-Mar-22 6:21 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 28-Feb-22 | Option Exercise | 4,105 | -- | -- | 26% 15.84K to 19.95K | |
11-Feb-22 10:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-22 | Payment of Exercise | 1,721 | $10.13 | $17,433.70 | (10%) 17.56K to 15.84K | |
11-Feb-22 10:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-22 | Option Exercise | 4,966 | -- | -- | 39% 12.6K to 17.56K | |
15-Jun-21 5:04 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 14-Jun-21 | Payment of Exercise | 417 | $9.72 | $4,053.24 | (3%) 13.01K to 12.6K | |
15-Jun-21 5:04 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 14-Jun-21 | Option Exercise | 1,420 | -- | -- | 12% 11.59K to 13.01K | |
02-Mar-21 7:26 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 28-Feb-21 | Payment of Exercise | 1,423 | $10.81 | $15,382.60 | (11%) 13.02K to 11.59K | |
02-Mar-21 7:26 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 28-Feb-21 | Option Exercise | 4,105 | -- | -- | 46% 8.91K to 13.02K | |
02-Jul-20 6:14 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 30-Jun-20 | Payment of Exercise | 12,049 | $0.76 | $9,121.09 | (12%) 101.19K to 89.14K | 38% |
02-Jul-20 6:14 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 30-Jun-20 | Option Exercise | 41,050 | -- | -- | 68% 60.14K to 101.19K | |
30-Jun-20 7:52 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Jun-20 | Payment of Exercise | 2,936 | $0.79 | $2,316.50 | (5%) 63.08K to 60.14K | 41% |
30-Jun-20 7:52 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Jun-20 | Option Exercise | 10,000 | -- | -- | 19% 53.08K to 63.08K | |
16-Jun-20 5:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 14-Jun-20 | Payment of Exercise | 4,168 | $0.83 | $3,441.10 | (7%) 57.25K to 53.08K | 43% |
16-Jun-20 5:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 14-Jun-20 | Option Exercise | 14,200 | -- | -- | 33% 43.05K to 57.25K | |
15-Oct-19 6:03 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 12-Oct-19 | Payment of Exercise | 2,450 | $2.11 | $5,157.25 | (5%) 45.5K to 43.05K | 78% |
28-Jun-19 5:04 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Jun-19 | Payment of Exercise | 2,940 | $1.65 | $4,851.00 | (6%) 48.44K to 45.5K | 72% |
28-Jun-19 5:04 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Jun-19 | Option Exercise | 10,000 | -- | -- | 26% 38.44K to 48.44K | |
17-Jun-19 5:40 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 14-Jun-19 | Payment of Exercise | 4,175 | $1.53 | $6,387.75 | (10%) 42.61K to 38.44K | 69% |
17-Jun-19 5:40 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 14-Jun-19 | Option Exercise | 14,200 | -- | -- | 50% 28.41K to 42.61K | |
21-Mar-19 5:24 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 19-Mar-19 | Payment of Exercise | 1,188 | $2.47 | $2,934.36 | (4%) 29.6K to 28.41K | 81% |
16-Oct-18 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 12-Oct-18 | Grant | 16,667 | -- | -- | 108% 15.39K to 32.05K | |
16-Oct-18 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 12-Oct-18 | Payment of Exercise | 2,455 | $3.23 | $7,929.65 | (8%) 32.05K to 29.6K | 86% |
29-Jun-18 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Jun-18 | Payment of Exercise | 2,945 | $1.86 | $5,477.70 | (16%) 18.33K to 15.39K | 75% |
29-Jun-18 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Jun-18 | Option Exercise | 10,000 | -- | -- | 120% 8.33K to 18.33K | |
21-Mar-18 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 19-Mar-18 | Grant | 8,333 | -- | -- | 100% 0 to 8.33K |